Advanced gene editing ‘promising’ for sickle cell disease, but access challenges remain

Key takeaways:

• Two studies highlight the potential of gene editing for sickle cell disease treatment.
• Despite increasing evidence of efficacy, high costs and manufacturing challenges have limited access to gene therapy.

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle cell disease.